Dokument: Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors

Titel:Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=72012
URN (NBN):urn:nbn:de:hbz:061-20260123-125348-3
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Bhave, Rigveda [Autor]
Kath, Carla-Johanna [Autor]
Rüchel, Nadine [Autor]
Vasileiou, Eleni [Autor]
Jepsen, Vera H. [Autor]
Raba, Katharina [Autor]
Pandyra, Aleksandra A. [Autor]
Pandyra, Aleksandra A. [Autor]
Kögler, Gesine [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]3,15 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 23.01.2026 / geändert 23.01.2026
Stichwörter:Culture media , B lymphocytes , Serum-free , Natural , Mesenchymal stem cells , Killer cells , Cord blood , Cell differentiation
Beschreibung:Pre-clinical research on B and NK cell development relies on murine stromal cell-based systems with reduced physiological relevance and clinical applicability. A serum-free, fully humanized co-culture system utilizing human bone marrow-derived mesenchymal stromal cells (BM-MSCs) was developed to differentiate CB-CD34+ cells towards B and NK cell lineages. Differentiation dynamics were monitored via flow cytometry, with immunophenotypic analysis tracking progression from progenitors to mature cells. The system generated CD19+ IgM+ immature B cells and CD56+ CD16+ NK cells, recapitulating fetal stages of human lymphopoiesis. Serum-free media conditions ensured reproducibility and high overall yield of CD19+ B (35 ± 5.32%) and CD56+ NK (28.46 ± 7.01%) cell progenitors. Flow cytometry identified distinct population peaks, confirming temporal control over differentiation. This clinically relevant platform addresses the limitations of traditional models by providing a more physiologically accurate human microenvironment. The serum-free system supports applications in disease modeling, genotoxic compound screening, and mutational studies of hematopoiesis. By enabling scalable production of B and NK cells it aims to accelerate translational research for immunodeficiencies, cancer immunotherapy, and hematopoietic disorders.
Rechtliche Vermerke:Originalveröffentlichung:
Bhave, R. N., Kath, C.-J., Rüchel, N., Vasileiou, E., Jepsen, V., Raba, K., Pandyra, A. A., Fischer, U., & Kögler, G. (2025). Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors. Scientific Reports, 15, Article 44132. https://doi.org/10.1038/s41598-025-30732-9
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:23.01.2026
Dateien geändert am:23.01.2026
english
Benutzer
Status: Gast
Aktionen